What Is MenaQ7®? Benefits, Dosing, and What to Look For
February 11, 20263 min read
MenaQ7® is a patented, clinically validated form of vitamin K2 as menaquinone-7 (MK-7). With the longest half-life of any vitamin K form, MK-7 activates proteins that direct calcium into bones and teeth while keeping it out of arteries and soft tissues. MenaQ7® is backed by multiple human clinical trials and is the gold standard for K2 supplementation.
What Is MenaQ7®?
MenaQ7® is a branded vitamin K2 ingredient manufactured by NattoPharma (now part of Gnosis by Lesaffre). It delivers menaquinone-7 (MK-7), a long-chain form of vitamin K2 derived from fermentation. While vitamin K1 (found in leafy greens) primarily supports blood clotting, vitamin K2 has distinct roles in calcium metabolism, bone health, and cardiovascular protection.
MK-7 is the preferred supplemental form of K2 because of its long half-life—roughly 72 hours compared to just a few hours for K1 or the shorter-chain MK-4. This extended activity means a single daily dose can maintain therapeutic blood levels around the clock.
How Does MenaQ7® Work?
Vitamin K2 activates two critical calcium-regulating proteins through a process called carboxylation. Osteocalcin, produced by osteoblasts, binds calcium and incorporates it into the bone matrix when activated by K2. Matrix Gla protein (MGP), found in blood vessel walls, prevents calcium from depositing in arterial tissue when carboxylated by K2.
Without sufficient K2, these proteins remain undercarboxylated and functionally inactive. The result: calcium may bypass bones and accumulate in arteries—a phenomenon sometimes called the “calcium paradox.” MenaQ7® ensures both osteocalcin and MGP are fully activated, supporting the body’s natural calcium-trafficking system.
What Does the Research Show?
The landmark three-year Knapen study, published in Thrombosis and Haemostasis, found that postmenopausal women taking 180 mcg of MenaQ7® daily experienced significantly improved bone mineral content and bone strength at the femoral neck, along with decreased arterial stiffness compared to placebo (PubMed: PMID 23525894). This is one of the few studies to demonstrate simultaneous bone and cardiovascular benefits from a single nutrient.
A dose-response study in the Journal of Bone and Mineral Research demonstrated that 90–180 mcg of MK-7 (as MenaQ7®) significantly increased the carboxylation of osteocalcin in healthy adults within six weeks (PubMed: PMID 23525894). Higher carboxylation correlated with improved bone metabolism markers.
Additional research in the journal Atherosclerosis confirmed that long-term MK-7 supplementation slowed age-related arterial stiffening, providing further evidence for K2’s cardiovascular benefits (PubMed: PMID 25169933).
Recommended Dosage and Forms
Clinical studies with MenaQ7® typically use doses of 90–180 mcg per day. The 180 mcg dose showed the broadest benefits across bone and cardiovascular outcomes. Because vitamin K2 is fat-soluble, taking it with a meal containing dietary fat improves absorption.
MenaQ7® is commonly found in softgels, capsules, and combination products with vitamin D3. The pairing of K2 + D3 is especially popular because vitamin D increases calcium absorption from the gut, while K2 ensures that calcium reaches the right destinations. When evaluating labels, look for the MenaQ7® name to confirm you’re getting the clinically studied form.
Potential Side Effects and Safety
MK-7 at supplemental doses of 90–360 mcg per day has demonstrated excellent safety in clinical trials. Vitamin K2 (MK-7) does not appear to promote excessive blood clotting at these doses, as its primary role is in calcium metabolism rather than coagulation.
However, individuals taking warfarin or other vitamin K antagonist anticoagulants should not supplement with K2 without medical supervision, as any form of vitamin K can affect anticoagulant dosing. Those on direct oral anticoagulants (DOACs) generally face fewer concerns but should still consult their healthcare provider.
Where to Find MenaQ7®
Utzy Naturals uses MenaQ7® across its vitamin K2 product line, including standalone Vitamin K2, the K2+D3 combination, and the Essentially-U multivitamin. By choosing MenaQ7®, Utzy Naturals ensures you get the same form of K2 validated in gold-standard clinical research—not a generic MK-7 of uncertain origin.
Vitamin K1 primarily supports blood clotting, while vitamin K2 (especially MK-7) activates proteins involved in calcium metabolism—directing calcium to bones and away from arteries.
Should I take K2 with vitamin D?
Yes. Vitamin D increases calcium absorption, and K2 ensures that calcium is deposited in bones rather than soft tissues. The two nutrients work synergistically for bone and cardiovascular health.
Can I get enough K2 from food?
K2 is found in fermented foods like natto, certain cheeses, and egg yolks, but dietary intake is often insufficient for optimal calcium metabolism. Supplementation provides consistent, clinically relevant doses.
Is MenaQ7® safe with blood thinners?
Individuals on warfarin should not supplement with K2 without medical supervision. Those on newer anticoagulants (DOACs) should also consult their healthcare provider before starting K2.
How much MenaQ7® should I take daily?
Clinical studies support 90–180 mcg per day. The 180 mcg dose has shown benefits for both bone density and arterial flexibility.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
